Justin R. Bailey

Justin R. Bailey

Infectious Disease | Hospital Medicine

1800 Orleans Street
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Divergent hepatitis B neutralizing antibody trajectories after spontaneous control in people with and without HIV.

Divergent hepatitis B neutralizing antibody trajectories after spontaneous control in people with and without HIV.

Journal: Research square

Published: August 20, 2026

Adapting in-cell ELISA to investigate the localization of hepatitis C virus envelope glycoproteins.

Adapting in-cell ELISA to investigate the localization of hepatitis C virus envelope glycoproteins.

Journal: Microbiology spectrum

Published: August 11, 2026

HIV causes global B-cell dysregulation and restricts HBV-specific B-cell development in an incident HBV cohort.

HIV causes global B-cell dysregulation and restricts HBV-specific B-cell development in an incident HBV cohort.

Journal: The Journal of clinical investigation

Published: April 07, 2026

mRNA-LNP hepatitis C vaccine encoding p7 elicits improved humoral immunogenicity.

mRNA-LNP hepatitis C vaccine encoding p7 elicits improved humoral immunogenicity.

Journal: Vaccine

Published: February 16, 2026

mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitope.

mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitope.

Journal: bioRxiv : the preprint server for biology

Published: January 16, 2026

Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent.

Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent.

Journal: The Journal of general virology

Published: January 13, 2026

HIV causes global B cell dysregulation and restricts HBV-specific B cell development in an incident HBV cohort.

HIV causes global B cell dysregulation and restricts HBV-specific B cell development in an incident HBV cohort.

Journal: The Journal of clinical investigation

Published: December 04, 2025

Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.

Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.

Journal: Journal of virology

Published: November 10, 2025

Single-cell hepatitis B sequencing reveals distinct viral infection events consistent with superinfection.

Single-cell hepatitis B sequencing reveals distinct viral infection events consistent with superinfection.

Journal: The Journal of infectious diseases

Published: October 30, 2025

Structural Repertoire of HCV Broadly Neutralizing Antibodies Targeting the E2 Front Layer Supersite.

Structural Repertoire of HCV Broadly Neutralizing Antibodies Targeting the E2 Front Layer Supersite.

Journal: bioRxiv : the preprint server for biology

Published: August 13, 2025

Structural repertoire of HCV broadly neutralizing antibodies targeting the E2 front layer supersite.

Structural repertoire of HCV broadly neutralizing antibodies targeting the E2 front layer supersite.

Journal: Structure (London, England : 1993)

Published: July 28, 2025

The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies.

The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies.

Journal: Hepatology (Baltimore, Md.)

Published: May 01, 2025

Showing 1-12 of 73

Last Updated: 09/26/2026